A study on the efficacy and safety assessment of Propionyl-L-carnitine tablets in treatment of intermittent claudication

Thrombosis Research

Volumn 132, Issue 4, 2013, Pages 427-432

  Luo, Tao ^a   Li, Jianxin ^a   Li, Li ^b   Yang, Baozhong ^c   Liu, Changjian ^d   Zheng, Qi ^e   Jin, Bi ^f   Chen, Zhong ^g   Li, Ke ^h   Zhang, Xiwei ⁱ   Zhang, Jian ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NANKAI UNIVERSITY AFFILIATED HOSPITAL   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^e Department of Oncology   (China)

^f HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^g CAPITAL MEDICAL UNIVERSITY   (China)

^h SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

ⁱ THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

clinical trial; intermittent claudication; peripheral arterial disease; Propionyl L carnitine; thrombosis

Indexed keywords

PLACEBO; PROPIONYLCARNITINE;

ANKLE BRACHIAL INDEX; ARTICLE; CHINESE; CLAUDICATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; TABLET; WALKING;

CLINICAL TRIAL; INTERMITTENT CLAUDICATION; PERIPHERAL ARTERIAL DISEASE; PROPIONYL-L-CARNITINE; THROMBOSIS;

ADMINISTRATION, ORAL; AGED; CARNITINE; DOUBLE-BLIND METHOD; HUMANS; INTERMITTENT CLAUDICATION; MIDDLE AGED; PENTOXIFYLLINE; PERIPHERAL ARTERIAL DISEASE; TREATMENT OUTCOME; WALKING;

EID: 84885172586     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.08.005     Document Type: Article

References (17)

1. Peripheral Arterial Disease at Merck Manual of Diagnosis and Therapy Professional Edition 2010 8
2. M.A. Stasi, M.G. Scioli, G. Arcuri, and G.G. Mattera Propionyl-L- carnitine improves postischemic blood flow recovery and arteriogenetic revascularization and reduces endothelial NADPH-oxidase 4-mediated superoxide production Arterioscler Thromb Vasc Biol 30 3 2010 426 435
3. Kenneth Ouriel Peripheral arterial disease Lancet 358 2001 1257 1264
4. B. Gregorio, P. Sergio, S. Carlo, D.M. Vincenzo, and C. Mario Propionyl-L-Carnitine in Intermittent Claudication: Double-Blind Placebo-Controlled, Dose Titration, Multicenter Study on the PLC JACC 26 6 1995 1411 1416
5. W.R. Hiatt, M.A. Creager, A. Amato, and E.P. Brass Effect of propionyl-L-carnitine on a background of monitored exercise in patients with claudication secondary to peripheral artery disease J Cardiopulm Rehabil Prev 31 2 2011 125 132
6. G.M. Andreozzi Propionyl-L-carnitine: intermittent claudication and peripheral arterial disease Expert Opin Pharmacother 10 16 2009 2697 2707
7. L. David, D. Curt, and B. Gregorio European multicenter study on propionyl-L-carnitine in intermittent claudication J Am Coll Cardiol 34 5 1999 1618 1624
8. W.R. Hiatt, and J.G. Regensteiner Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication Am J Med 110 8 2001 616 622
9. G. Brevetti, S. Perna, and C. Sabba Effect of propionyl-L-carnitine on quality of life in intermittent claudication Am J Cardiol 79 6 1997 777 780
10. K. Whitfield, A. Rambaldi, J. Wetterslev, and C. Gluud Pentoxifylline for alcoholic hepatitis Cochrane Database Syst Rev 7 4 2009 CD007339
11. E.P. Brass, D. Koster, W.R. Hiatt, and A. Amato A systematic review and meta-analysis of propionyl-L-carnitine effects on exercise performance in patients with claudication Vasc Med 18 1 2013 3 12
12. M.A. de Sotomayor, C. Mingorance, R. Rodriguez-Rodriguez, E. Marhuenda, and M.D. Herrera l-carnitine and its propionate: improvement of endothelial function in SHR through superoxide dismutase-dependent mechanisms Free Radic Res 4 2007 884 891
13. R. Micheletti, G. Giacalone, and G. Bianchi Effect of propionyl-L-carnitine on the mechanics of right and left papillary muscles from volume-overloaded rat hearts J Cardiovasc Pharmacol 27 1996 52 57
14. A.W. Gardner, J.S. Skinner, and B.W. Cantwell Progressive vs single-stage treadmill tests for evaluation of claudication Med Sci Sports Exerc 23 1991 402 408
15. L. Loffredo, P. Pignatelli, R. Cangemi, P. Andreozzi, M.A. Panico, and V. Meloni Imbalance between nitric oxide generation and oxidative stress in patients with peripheral arterial disease: effect of an antioxidant treatment J Vasc Surg 44 3 2006 525 530
16. G.A. Barker, S. Green, C.D. Askew, A.A. Green, and P.J. Walker Effects of propionyl-L-carnitine on exercise performance in peripheral arterial disease Med Sci Sports Exerc 33 2001 1415 1422
17. A. Miccheli, P. Sapienza, M. Tedesco, A. Mingoli, G. Capuani, and T. Aureli 31Phosphorus magnetic resonance spectroscopy to evaluate medical therapy efficacy in peripheral arterial disease. A pilot study Panminerva Med 41 4 1999 283 290